BMY vs GAIA · P/E 17, rev $24.46B vs rev $47.6M
Bristol-Myers Squibb Company (BMY) versus Gaia Inc (GAIA) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Gaia Inc (GAIA) is a entertainment company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported GAIA revenue for 2026-06-30 was $47.6M. Net income was -$4.3M. Revenue was up 96.0% from 2026-03-31 to 2026-06-30. GAIA currently screens at market cap $59.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. GAIA currently screens at market cap $59.2M.
Not investment advice. Open the BMY and GAIA stock pages for the full models.
Not investment advice.